Agilon Health, Inc. (NYSE:AGL) Receives Consensus Recommendation of “Hold” from Analysts

Agilon Health, Inc. (NYSE:AGL) has earned an average recommendation of “Hold” from the fifteen analysts that are currently covering the firm, Marketbeat Ratings reports. Two investment analysts have rated the stock with a sell rating, eight have issued a hold rating and five have given a buy rating to the company. The average twelve-month target price among analysts that have issued ratings on the stock in the last year is $58.7273.

A number of brokerages have recently issued reports on AGL. Barclays upgraded shares of Agilon Health from an “underweight” rating to an “equal weight” rating and set a $81.00 target price on the stock in a research report on Tuesday, May 26th. JPMorgan Chase & Co. lowered shares of Agilon Health from a “neutral” rating to an “underweight” rating and set a $21.00 target price on the stock. in a research report on Monday, May 4th. Wall Street Zen upgraded shares of Agilon Health from a “sell” rating to a “hold” rating in a research report on Saturday, May 9th. Weiss Ratings lowered shares of Agilon Health from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Wednesday, May 27th. Finally, Benchmark restated a “buy” rating and set a $95.00 target price (up from $13.00) on shares of Agilon Health in a research report on Thursday, May 21st.

Hedge Funds Weigh In On Agilon Health

Hedge funds and other institutional investors have recently bought and sold shares of the company. Wealthcare Advisory Partners LLC purchased a new position in Agilon Health in the 3rd quarter valued at $26,000. LPL Financial LLC grew its position in Agilon Health by 213.4% in the 4th quarter. LPL Financial LLC now owns 44,055 shares of the company’s stock valued at $30,000 after buying an additional 30,000 shares during the last quarter. Krilogy Financial LLC purchased a new position in Agilon Health in the 4th quarter valued at $34,000. CIBC Bancorp USA Inc. purchased a new position in Agilon Health in the 3rd quarter valued at $34,000. Finally, Merit Financial Group LLC purchased a new position in Agilon Health in the 4th quarter valued at $35,000.

Agilon Health Stock Performance

Shares of AGL opened at $86.47 on Wednesday. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.08. The firm has a market cap of $1.44 billion, a PE ratio of -4.01 and a beta of 3.02. The company’s 50 day simple moving average is $41.17 and its 200-day simple moving average is $25.43. Agilon Health has a 12-month low of $7.48 and a 12-month high of $94.71.

Agilon Health (NYSE:AGL) last announced its earnings results on Wednesday, May 6th. The company reported $1.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.04 by $0.76. The business had revenue of $1.42 billion for the quarter, compared to analyst estimates of $1.38 billion. Agilon Health had a negative net margin of 6.09% and a negative return on equity of 146.03%. As a group, equities analysts predict that Agilon Health will post -3.5 EPS for the current year.

Agilon Health Company Profile

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.